Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineAdefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026
See the DrugPatentWatch profile for rifaximin
Yes. Rifaximin is an oral antibiotic. It acts in the gut by inhibiting bacterial RNA synthesis, which reduces growth of susceptible bacteria in the intestinal tract.
Rifaximin is considered a gut-selective (non-systemic) antibiotic because most of the drug stays in the gastrointestinal tract rather than being widely absorbed into the bloodstream. That gut-focused activity is why it’s used for certain intestinal conditions where reducing specific bacteria in the gut is the goal.
Rifaximin is used for conditions such as traveler’s diarrhea (certain cases), hepatic encephalopathy (to help reduce episodes), and other gastrointestinal bacterial overgrowth-related indications, depending on the country and labeling.
In general terms, yes—it targets bacteria and is used to treat bacterial-related conditions. The key practical difference is its gut-focused activity, which tends to limit whole-body exposure compared with many broad-spectrum systemic antibiotics. Sources No sources provided.
Other Questions About Rifaximin :